Technology | Ultrasound Imaging | October 17, 2017

Philips Receives FDA 510(k) Clearance to Market Small Parts Ultrasound Solution

One-transducer solution and tailored clinical tools for 'small parts' ultrasound imaging assess diseases and disorders in one of the fastest growing segments of ultrasound exams

 Philips-MicroFlow-Imaging-testicular-ultrasound
 Philips-eL18-4-PureWave-ultrasound-transducer-thyroid

October 17, 2017 — Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the new eL18-4 transducer with full solution for 'small parts' assessment. These ultrasound exams detect abnormalities in the small organs that are close to the skin. The Philips Ultimate Small Parts Solution features four key innovations that work together to help improve patient care: the eL18-4 PureWave linear array transducer, Philips MicroFlow Imaging, Philips Elastography and Philips Precision Biopsy. The new eL18-4 transducer can also be used to assess musculoskeletal injuries.

Philips will debut this latest solution, which is available on Philips Epiq 7 and 5 and Affiniti 70 ultrasound systems, at the 16th World Federation for Ultrasound in Medicine and Biology (WFUMB) Congress, Oct. 13-17 in Taipei, Taiwan.

Small parts imaging is a rapidly growing segment of ultrasound examinations for clinicians around the world. Its broad set of applications include assessment of diseases and disorders of small organs such as breasts, testicles and thyroid, as well as musculoskeletal injuries like sprains and tears. High-resolution ultrasound, such as that available on Philips Epiq and Affiniti solutions, allows clinicians to visualize and characterize abnormalities and evaluate organ blood flow, guide treatment and perform biopsies of suspicious lesions.

"My clinical experience with the new Philips eL18-4 small parts transducer has enabled excellent versatility and penetration that could easily replace my current transducers," said Lynwood Hammers, DO, Hammers Healthcare Imaging, New Haven, Conn. "I am able to see subtle lesions with great detail and excellent sensitivity for small vessel details. In my opinion, this new small parts transducer definitely elevates my clinical confidence and decreases indeterminate diagnosis."

The Philips Epiq Ultimate Small Parts Solution is comprised of a suite of features for small parts assessment. These include:

  • The Philips eL18-4 transducer allows fine-elevation focusing to deliver exceptional detail resolution and tissue uniformity for clinical solutions, including: thyroid, breast, testicular, musculoskeletal, vascular, bowel, pediatrics and obstetrics;
  • Philips MicroFlow Imaging provides remarkable sensitivity and detail for small vessel blood flow assessment;
  • Complete Elastography solution with both strain and ElastQ Imaging shear wave capability reveals definitive information on tissue stiffness; and
  • New precision biopsy capabilities help minimize needle blind zones and support the ability to enhance the display of needle reflections – all to elevate confidence during interventional procedures.

For more information: www.usa.philips.com/healthcare

Related Content

New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

News | Artificial Intelligence | May 07, 2021
SmartXR uses a unique combination of hardware and AI-powered software to lighten radiographers’ workloads and provide image acquisition support.

SmartXR uses a unique combination of hardware and AI-powered software to lighten radiographers’ workloads and provide image acquisition support. 

Feature | Digital Radiography (DR) | May 04, 2021 | By Melinda Taschetta-Millane
The COVID-19 pandemic brought about an uptick in
A 63-year-old multiple #myeloma patient, with skeletal pain. New #FDG avid axillary #lymphadenopathy 62 days (9 weeks) after second #mRNA #vaccination dose. Image used with permission of the Radiological Society of North America (#RSNA)

A 63-year-old multiple myeloma patient, with skeletal pain. New FDG avid axillary lymphadenopathy 62 days (9 weeks) after second mRNA vaccination dose. Image used with permission of the Radiological Society of North America (RSNA)

Feature | Coronavirus (COVID-19) | April 29, 2021 | By Melinda Taschetta-Millane
Overview of the scaphoid fracture detection pipeline, which consisted of a segmentation and detection convolutional neural network (CNN). A class activation map is calculated and visualized as a heatmap for fracture localization. Image courtesy of Radiological Society of North America

Overview of the scaphoid fracture detection pipeline, which consisted of a segmentation and detection convolutional neural network (CNN). A class activation map is calculated and visualized as a heatmap for fracture localization. Image courtesy of the Radiological Society of North America

News | Artificial Intelligence | April 28, 2021
April 28, 2021 — An automated system that uses...
Examples of axial FLAIR sequences from studies within dataset A. From left to right: a patient with a 'likely normal' brain; a patient presenting an intraparenchymal hemorrhage within the right temporal lobe; a patient presenting an acute infarct of the inferior division of the right middle cerebral artery; and a patient with known neurocysticercosis presenting a rounded cystic lesion in the left middle frontal gyrus. Image courtesy of Radiological Society of North America

Examples of axial FLAIR sequences from studies within dataset A. From left to right: a patient with a 'likely normal' brain; a patient presenting an intraparenchymal hemorrhage within the right temporal lobe; a patient presenting an acute infarct of the inferior division of the right middle cerebral artery; and a patient with known neurocysticercosis presenting a rounded cystic lesion in the left middle frontal gyrus. Image courtesy of Radiological Society of North America

News | Artificial Intelligence | April 22, 2021
April 22, 2021 — An artificial intellige...
Spectral DLR enables improved assessment of lumen stenosis in the presence of calcified plaque. Interactive monochromatic image display enables improved opacification of the injected contrast with low keV images and reduced calcium blooming artifacts with high keV images

Spectral DLR enables improved assessment of lumen stenosis in the presence of calcified plaque. Interactive monochromatic image display enables improved opacification of the injected contrast with low keV images and reduced calcium blooming artifacts with high keV images. The range of monochromatic energy levels (35-135 keV) can be visualized in real time through an image slider in the application that can be integrated in to a PACS.

News | Cardiac Imaging | April 21, 2021
April 21, 2021 — Meeting the growing cardiovascular needs of healthcare providers today, ...
Low-dose #CT #lung #scans are used to #screen for #lung_cancer in high-risk people such as heavy #smokers

Getty Images

News | Lung Imaging | April 16, 2021
April 17, 2021 — A deep learning algorithm accurately predicts the risk of death from...
#SiemensHealthineers #Varian #Siemens The transformative combination accelerates the company’s impact on #global #healthcare and establishes a strong partner for #customers and #patients along the entire #cancer care continuum and for many of the most threatening #diseases
News | Radiology Business | April 15, 2021
April 15, 2021 — Siemens Healthineers AG an